Covalent inhibitors of the PI3Kα RAS binding domain impair tumor growth driven by RAS and HER2Joseph E. Klebba, Matthew P. Patricelli, Melissa Hoffman et al.|Science|2025Cited by 12
Abstract C081: Discovery and characterization of AKT1-E17K mutant-selective inhibitors for the treatment of AKT1-E17K mutant cancersTine Wyseure, Matt Patricelli, Noah Ibrahim et al.|Molecular Cancer Therapeutics|2025Cited by 0